|
TSG101 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.158500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.737940E-03 |
| Normal-vs-Stage2 |
9.336100E-02 |
| Normal-vs-Stage3 |
2.261400E-01 |
| Normal-vs-Stage4 |
7.583200E-04 |
| Stage1-vs-Stage2 |
5.572600E-01 |
| Stage1-vs-Stage3 |
3.062200E-01 |
| Stage1-vs-Stage4 |
9.841500E-02 |
| Stage2-vs-Stage3 |
7.676200E-01 |
| Stage2-vs-Stage4 |
8.472100E-02 |
| Stage3-vs-Stage4 |
8.926300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.205700E-04 |
| Normal-vs-AfricanAmerican |
4.976400E-02 |
| Normal-vs-Asian |
4.997800E-01 |
| Caucasian-vs-AfricanAmerican |
3.908200E-01 |
| Caucasian-vs-Asian |
8.314400E-01 |
| AfricanAmerican-vs-Asian |
9.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.976700E-04 |
| Normal-vs-Female |
7.968000E-02 |
| Male-vs-Female |
8.959600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.587500E-02 |
| Normal-vs-Extreme_Weight |
1.917490E-03 |
| Normal-vs-Obese |
2.211600E-02 |
| Normal-vs-Extreme_Obese |
1.610390E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.930000E-01 |
| Normal_Weight-vs-Obese |
9.782800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.190600E-01 |
| Extreme_Weight-vs-Obese |
3.139000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.799600E-01 |
| Obese-vs-Extreme_Obese |
4.681600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.085800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.639800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.229200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.573450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.964400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.449890E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.391370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.956410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.264000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.557470E-03 |
| Normal-VS-Type2 PRCC |
2.455900E-02 |
| Normal-VS-KIRP CIMP |
2.668800E-01 |
| Normal-VS-Unclassified PRCC |
1.152460E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.289400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.537000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.479800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.411800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.533800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.651200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.242330E-03 |
| Normal-vs-N1 |
1.466760E-01 |
| Normal-vs-N2 |
5.016600E-04 |
| N0-vs-N1 |
3.277600E-01 |
| N0-vs-N2 |
1.562770E-01 |
| N1-vs-N2 |
8.722100E-02 |
|
|
